given a gavage of saline (0.1 mL·kg -1 ·d -1 ). Eight weeks later, the sexual behavior was investigated by the copulatory test, the morphological change of prostatic tissue was observed by light microscopy after HE staining, cytokines (TNF-α, IL-1β) in serum were detected by ELISA, the levels of 5-HT, 5-HT1A receptor, 5-HT2C receptor and SERT in T13-L2 and L5-S2 spinal cord tissue were detected by immunohistochemical staining and Western Blot. Results: In model group, prostatic inflammation was found in 12 rats, and not in another 4 rats. The 4 rats were not included in the statistical analysis. In normal control group, prostatic inflammation was not found. In the celecoxib treatment group, there was a small amount of interstitial infiltration of inflammatory cells in rat's prostate. In the copulatory test, compared with normal control group, mount latency (ML) and intromission latency (IL) in the model group were significantly prolonged (P<0.05); ejaculation latency (EL) in the model group was significantly shortened (P<0.05). There was no significant difference in these sexual behavior parameters between the normal control group and the celecoxib treatment group (P>0.05). Serum IL-1β and TNF-α levels in the model group were significantly higher than that in the control group (P<0.01). There was no significant difference in the levels of IL-1β and TNF-α between the normal control group and the celecoxib treatment group (P>0.05). In T13-L2 spinal cord tissue, compared with normal control group, 5-HT levels in the model group were significantly lower (P<0.05), 5-HT1A receptor levels in the model group were significantly increased (P<0.05), while the 5-HT2C receptor and SERT levels in the model group did not change significantly (P>0.05). In L5-S2 spinal cord tissues, compared with normal control group, 5-HT levels in the model group were significantly lower (P<0.05), while the 5-HT1A, 5-HT2C and SERT levels in the model group increased slightly, but the differences in 5-HT1A, 5-HT2C and SERT levels between the model group and the normal control group were statistically significant (P<0.05). There were not significant differences in 5-HT, 5-HT1A, 5-HT2C and SERT levels between the normal control group and the celecoxib treatment group (P>0.05). Conclusions: EAP shorten rat's EL by changing the levels of 5-HT and its receptors, SERT in spinal cord. Cox-2 inhibitors can prolong EL of EAP rat, the mechanisms might be that it can relieve inflammation of the prostate, reverse the effect of EAP on spinal cord 5-HT transmitter system. Cox-2 inhibitors can be used in the treatment of premature ejaculation caused by prostatitis. 
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AB037. Icariside II improves human cavernous endothelial cells function by regulating miR-155/eNOS signal pathway
Background: To investigate the changes of miR-155/ endothelial nitric oxide synthase (eNOS) signal pathway under the stimulation of age-BSA and glucose with or without icariside II (ICAII) intervention inhuman cavernous endothelial cells (HCECs). Methods: Purified HCECs were first divided into three groups randomly: normal group + BSA (NC group), age-BSA + glucose group (DM group), ICAII treatment group (DM + ICAII group with different concentrations at 0.1, 1, 10 μM). Western Blot to detect the protein expression of eNOS and RAGE; real time PCR to detect the expression of miR-155 and eNOS; DAF-FM DA fluorescent probes assay and NaNO 3 /NaNO 2 assay to detect the NO concentration. Lentivirus mediated miR-155 overexpression was constructed to observe the changes of eNOS and NO. Results: The eNOS and RAGE expression in DM group is significantly reduced and increased respectively compared with that of NC group (P<0.05), while ICAII intervention could reverse this change effectively. The 10 μM of ICAII has the most powerful effect. MiR-155 has the highest fold changes among candidate miRNAs in diabetic like HCECs (P<0.05). MiR-155 increased and eNOS decreased remarkably in DM group, while ICAII intervention could inhibit the miR-155 expression, which led to the significantly higher eNOS expression and NO concentration (P<0.05). In lentivirus mediated miR-155 overexpression with or without ICAII intervention model, we found the similar trend with the above diabetic model. Conclusions: MiR-155/eNOS signal pathway may be involved in the process of diabetic HCECs dysfunction. ICAII could promote the recovery of the endothelial dysfunction by regulating the miR-155/eNOS signal pathway. AB038. High tropomyosin related kinase (TrkB) expression induces epithelialmesenchymal transition, anoikis resistance and metastasis in prostatic cancer cells
